Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-16 4:29 pm Sale | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | PRICE T ROWE ASSOCIATES INC | 1,444,950 2.5% | -9,424,610 (-86.71%) | View |
| 2024-02-14 5:01 pm Purchase | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | RA CAPITAL MANAGEMENT L.P. | 10,107,400 17.5% | 140,228 (+1.41%) | View |
| 2024-02-14 4:21 pm Sale | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | BAKER BROS. ADVISORS LP | 0 0% | -4,954,855 (Position Closed) | View |
| 2024-02-14 10:04 am Purchase | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | T. Rowe Price Investment Management Inc. | 3,989,830 6.9% | 3,989,830 (New Position) | View |
| 2024-02-14 10:03 am Purchase | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | PRICE T ROWE ASSOCIATES INC | 10,869,560 2.5% | 7,159,719 (+192.99%) | View |
| 2024-02-14 09:17 am Purchase | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | Avoro Capital Advisors LLC | 3,755,555 6.5% | 655,555 (+21.15%) | View |
| 2024-02-13 11:57 am Purchase | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | JANUS HENDERSON GROUP PLC JHG | 3,994,785 6.9% | 350,830 (+9.63%) | View |
| 2024-02-12 06:12 am Sale | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | Artisan Partners Limited Partnership | 5,749,227 10% | -1,171,129 (-16.92%) | View |
| 2024-02-09 08:35 am Sale | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | FMR LLC | 5,114,369 9.067% | -114,701 (-2.19%) | View |
| 2024-02-08 10:03 am Purchase | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | WELLINGTON MANAGEMENT GROUP LLP | 3,248,293 5.77% | 172,281 (+5.60%) | View |
| 2024-02-02 1:18 pm Purchase | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | WESTFIELD CAPITAL MANAGEMENT CO LP | 4,030,634 7.05% | 872,466 (+27.63%) | View |
| 2023-04-10 5:00 pm Purchase | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | RA CAPITAL MANAGEMENT L.P. | 9,967,172 17.4% | 3,009,993 (+43.26%) | View |
| 2023-02-14 4:45 pm Sale | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | RA CAPITAL MANAGEMENT L.P. | 6,957,179 12.2% | -610,721 (-8.07%) | View |
| 2023-02-14 4:00 pm Purchase | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | BAKER BROS. ADVISORS LP | 4,954,855 8.7% | 413,251 (+9.10%) | View |
| 2023-02-14 12:38 pm Sale | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | PRICE T ROWE ASSOCIATES INC | 3,709,841 6.5% | -1,051,352 (-22.08%) | View |
| 2023-02-14 09:33 am Purchase | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | Avoro Capital Advisors LLC | 3,100,000 5.4% | 3,100,000 (New Position) | View |
| 2023-02-10 10:01 am Purchase | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | JANUS HENDERSON GROUP PLC JHG | 3,643,955 6.4% | 423,990 (+13.17%) | View |
| 2023-02-10 09:11 am Sale | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | Artisan Partners Limited Partnership | 6,920,356 12.1% | -1,020,078 (-12.85%) | View |
| 2023-02-09 08:23 am Sale | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | FMR LLC | 5,229,070 9.271% | -126,873 (-2.37%) | View |
| 2023-02-06 2:36 pm Sale | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | WELLINGTON MANAGEMENT GROUP LLP | 3,076,012 5.4% | -992,464 (-24.39%) | View |